JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Healthcare | 12.84% |
| 3 | Financials | 10.61% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 7.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1826
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $15M | ﹤0.01% |
699,093
-110,940
| -14% | -$2.37M |
|
1827
Northwest Natural Holdings
NWN
$2.13B
| $14.9M | ﹤0.01% |
314,030
+126,147
| +67% | +$5.91M |
|
1828
Ecopetrol
EC
$35.8B
| $14.9M | ﹤0.01% |
1,427,074
+1,622
| +0.1% | +$15.8K |
|
1829
Iovance Biotherapeutics
IOVA
$2.94B
| $14.9M | ﹤0.01% |
2,336,120
+222,842
| +11% | +$1.74M |
|
1830
KE Holdings
BEKE
$18.7B
| $14.9M | ﹤0.01% |
1,069,022
-16,268,774
| -94% | -$226M |
|
1831
PUT
Ralph Lauren
RL
$23.2B
| $14.9M | ﹤0.01% |
+141,100
| New | +$14.1M |
|
|
UMH
1832
UMH Properties
UMH
$1.4B
| $14.9M | ﹤0.01% |
923,943
+475,945
| +106% | +$8.01M |
|
1833
Associated Banc-Corp
ASB
$6.09B
| $14.9M | ﹤0.01% |
643,482
-117,107
| -15% | -$2.7M |
|
1834
NewMarket
NEU
$8.73B
| $14.8M | ﹤0.01% |
47,657
-1,152
| -2% | -$354K |
|
1835
CALL
Philip Morris
PM
$296B
| $14.8M | ﹤0.01% |
146,400
-20,600
| -12% | -$1.94M |
|
1836
Fate Therapeutics
FATE
$296M
| $14.8M | ﹤0.01% |
1,467,004
-566,199
| -28% | -$10.6M |
|
|
CALY
1837
Callaway Golf Company
CALY
$2.95B
| $14.8M | ﹤0.01% |
748,443
+465,686
| +165% | +$9.17M |
|
1838
Texas Pacific Land
TPL
$24.6B
| $14.8M | ﹤0.01% |
56,727
+1,062
| +2% | +$281K |
|
1839
CALL
Adobe
ADBE
$105B
| $14.8M | ﹤0.01% |
43,900
+700
| +2% | +$224K |
|
1840
Adient
ADNT
$1.59B
| $14.7M | ﹤0.01% |
425,184
-8,879
| -2% | -$310K |
|
1841
PUT
Verizon
VZ
$201B
| $14.7M | ﹤0.01% |
373,700
+61,800
| +20% | +$2.33M |
|
1842
CALL
Prudential Financial
PRU
$43.1B
| $14.7M | ﹤0.01% |
148,000
+3,600
| +2% | +$365K |
|
1843
Liberty Media Series A
FWONA
$24.2B
| $14.7M | ﹤0.01% |
287,742
+21,046
| +8% | +$1.07M |
|
|
SNV
1844
DELISTED
Synovus
SNV
| $14.7M | ﹤0.01% |
391,856
+1,197
| +0.3% | +$47.5K |
|
1845
Peabody Energy
BTU
$3.07B
| $14.7M | ﹤0.01% |
555,133
+116,290
| +26% | +$3.2M |
|
1846
Dimensional US Core Equity 2 ETF
DFAC
$49.9B
| $14.7M | ﹤0.01% |
603,820
+602,396
| +42,303% | +$14.7M |
|
1847
Sony
SONY
$142B
| $14.6M | ﹤0.01% |
958,685
-83,475
| -8% | -$1.25M |
|
1848
Andersons Inc
ANDE
$2.24B
| $14.6M | ﹤0.01% |
417,897
-118,837
| -22% | -$4.22M |
|
|
AJXA
1849
DELISTED
Great Ajax Corp.7.25% Convertible Senior Notes due 2024
AJXA
| $14.6M | ﹤0.01% |
609,657
-4,510
| -0.7% | -$109K |
|
|
BRKL
1850
DELISTED
Brookline Bancorp
BRKL
| $14.6M | ﹤0.01% |
1,029,315
-156,879
| -13% | -$2.1M |
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 753 new, 2,941 increased, 2,285 reduced and 594 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 753 new positions and closed 594 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.